Holen Sie sich die Stockscreener-App
3.29
0.45%
-0.015
Schlusskurs vom Vortag:
$3.305
Offen:
$3.34
24-Stunden-Volumen:
47,033
Relative Volume:
1.29
Marktkapitalisierung:
$28.63M
Einnahmen:
$9.72M
Nettoeinkommen (Verlust:
$-6.64M
KGV:
-4.129
EPS:
-0.7968
Netto-Cashflow:
$-7.57M
1W Leistung:
+1.54%
1M Leistung:
-27.37%
6M Leistung:
-23.43%
1J Leistung:
-20.25%
1-Tages-Spanne:
$3.15
$3.34
1-Wochen-Bereich:
$3.11
$3.465
52-Wochen-Spanne:
$3.11
$6.96
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Firmenname
Neuroone Medical Technologies Corp
Sektor
Branche
Telefon
(952) 426-1383
Adresse
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.38 | 3.16B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.54 | 425.01M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.909 | 269.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.61 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-29 | Herabstufung | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
NeuroOne Medical Technologies Corp. Hits 52-Week Low at $3.16 Amid Challenges - MarketsMojo
NeuroOne Medical Technologies Corp (NMTC) Institutional Confidence - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NeuroOne Medical Technologies Corp - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
NeuroOne Medical Technologies 10-Q/A Restatement for Q2 2026 – Financial Statement Corrections and Impact - Minichart
NeuroOne Medical Technologies Corporation Files Form 8-K Current Report with NASDAQ Listing Information - Minichart
NeuroOne Medical Technologies updates at-the-market offering for up to $13.4 million - Investing.com
NeuroOne to sell up to $13.4M in common stock through updated ATM prospectus - TradingView
NeuroOne (NASDAQ: NMTC) ups at‑the‑market capacity to $13.4M via JonesTrading - Stock Titan
NeuroOne Medical Technologies (NMTC) refreshes $13.4M at-the-market share offering - Stock Titan
NeuroOne Medical (NASDAQ: NMTC) restates revenue and warns on going concern - Stock Titan
NMTC Q1 2026 Earnings: EPS Misses Estimates as Development-Stage Costs PersistGeographic Revenue Trends - newsline.com
NeuroOne (NMTC) Q2 2026 Earnings Transcript - AOL.com
NMTCNeuroOne Medical Technologies Corporation stock news, filings & ratings - Quantisnow
NeuroOne Medical | 4: Statement of changes in beneficial ownership of securities-Officer Christianson Mark - Moomoo
NeuroOne Medical Technologies to Restate Q1 2026 Financials After Revenue Overstatement; Reaffirms $10.5M FY2026 Guidance - Minichart
According to documents submitted by NEUROONE MEDICAL TECH to the U.S. Securities and Exchange Commission, the company has restated its financial data for the first quarter of 2026 to correct a previous overstatement of revenue by approximately $50 - Bitget
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 - Scott Coop
NeuroOne (Nasdaq: NMTC) to restate March 31 2026 results, keeps guidance - Stock Titan
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises - Investing.com
Minne InnoNeuroOne CEO Dave Rosa talks uplisting on Nasdaq, year ahead - The Business Journals
Maxim Group Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $13 - Moomoo
NMTC Maintains Buy Rating by Ladenburg Thalmann -- Price Target Raised to $8.80 - GuruFocus
NeuroOne Medical Tech Price Target Raised to $8.00/Share From $1.60 by Ladenburg Thalmann - Moomoo
NeuroOne Medical Tech Q2 2026 Earnings Call Transcript - Sahm
NeuroOne Medical (NMTC) Price Target Raised to $8 - GuruFocus
Ladenburg Thalmann Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
NeuroOne Medical Technologies Corp 2026 Q2 Financial Report: Revenue, Product Updates, and Financial Statements - Minichart
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call - GuruFocus
Q2 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock dips - Investing.com India
Is NeuroOne Medical Technologies (NMTC) 42.2% Undervalued or a P - GuruFocus
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock dips By Investing.com - Investing.com Canada
NEUROONE MEDICAL TECHNOLOGIES Corp 2Q 2026: Revenue $2.39M, EPS ($0.25) — 10-Q Summary - TradingView
NeuroOne Medical | 10-Q: Q2 2026 Earnings Report - Moomoo
NeuroOne (NASDAQ: NMTC) grows sales but warns on going concern - Stock Titan
NeuroOne posts Q2 fiscal 2026: Product revenue $2.4M, net loss $2.1M - TradingView
NeuroOne (Nasdaq: NMTC) Q2 revenue jumps 72% while net loss persists - Stock Titan
EQS-News: NeuroOne Medical Technologies: NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update - FinanzNachrichten.de
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Repor - GuruFocus
NeuroOne Medical | 8-K: Current report - Moomoo
NeuroOne Medical Technologies Corp expected to post a loss of 23 cents a shareEarnings Preview - TradingView
NeuroOne Medical Technologies Corporation Receives Nasdaq Deficiency Notice for Minimum Bid Price Compliance – 8-K Filing April 30, 2026 - Minichart
NeuroOne (NASDAQ: NMTC) restores compliance with Nasdaq $1.00 bid rule - Stock Titan
Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neuroone Medical Technologies Corp-Aktie (NMTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Business Development Director |
Mar 12 '26 |
Sale |
0.80 |
817 |
654 |
214,383 |
| Christianson Mark | Business Development Director |
Mar 13 '26 |
Sale |
0.80 |
100 |
80 |
214,283 |
| Christianson Mark | Business Development Director |
Mar 10 '26 |
Sale |
0.80 |
11,611 |
9,289 |
217,309 |
| Christianson Mark | Business Development Director |
Mar 11 '26 |
Sale |
0.80 |
2,109 |
1,687 |
215,200 |
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):